Dean S. Elterman¹, Kevin C. Zorn², Bilal Chughtai³, Naeem Bhojani²

Canadian Journal of Urology, Vol.28, No.2, pp. 10580-10583, 2021

Abstract Introduction: The options for treating benign prostatic hyperplasia (BPH) beyond medication and traditional transurethral surgery continue to expand. Undesirable side effects of medication and surgeries have driven interest toward minimally invasive surgical therapies (MISTs), including convective water vapor ablation (Rezum) and prostatic urethral lift (UroLift). While these treatments can be performed outside of the operating room, they do require special equipment and the use of rigid cystoscopy. A new class of treatments, which utilize no special equipment beyond a flexible cystoscope, is emerging, the first of which, the temporary implantable nitinol device (iTind), is already FDA… More >

Dean Elterman¹, Bruce Gao¹, Kevin C. Zorn², Naeem Bhojani², Bilal Chughtai³

Canadian Journal of Urology, Vol.28, No.4, pp. 10788-10793, 2021

Abstract Benignprostatichyperplasiaisacommonandprogressive diseaseaffectingagingmenwhichhasasignifcantimpact on quality of life. The second-generation Temporarily Implanted Nitinol Device (iTind) is an FDA approved temporaryprostaticurethraldevicewhichcanbedeployed using standard fexible cystoscopy without sedation or generalanesthesia.Thedeviceisleftin-situfor5to7days and is then entirely removed in the offce, using an open-ended silicone catheter. Prospective, randomized data indicate that iTind has favorable functional and sexual patient outcomes. Readers will familiarize themselves withiTind,signifcanthistoricalstudiesandthetechnique for deploying iTind using a fexible cystoscope in the offce setting. More >

Ayesha Riaz¹, Naveed Riaz¹, Awais Mahmood^2,*, Sajid Ali Khan³, Imran Mahmood¹, Omar Almutiry², Habib Dhahri²

CMC-Computers, Materials & Continua, Vol.67, No.3, pp. 2747-2764, 2021, DOI:10.32604/cmc.2021.014418 - 01 March 2021

Abstract The COVID-19 outbreak and its medical distancing phenomenon have effectively turned the global healthcare challenge into an opportunity for Telecare Medical Information Systems. Such systems employ the latest mobile and digital technologies and provide several advantages like minimal physical contact between patient and healthcare provider, easy mobility, easy access, consistent patient engagement, and cost-effectiveness. Any leakage or unauthorized access to users’ medical data can have serious consequences for any medical information system. The majority of such systems thus rely on biometrics for authenticated access but biometric systems are also prone to a variety of attacks… More >